Meeder Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Meeder Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4	Closed	–	–	2291
2020 Q3	$0	Hold	4	–	–	﹤0.01%	2422
2020 Q2	$0	Hold	4	–	–	﹤0.01%	2559
2020 Q1	$0	Buy	4 +1	+33%	+$39	﹤0.01%	2583
2019 Q4	$0	Buy	+3	New	+$66	﹤0.01%	2450
2019 Q2	–	Sell	-152	Closed	-$9K	–	2173
2019 Q1	$9K	Hold	152	–	–	﹤0.01%	1278
2018 Q4	$7K	Sell	152 -42	-22%	-$2.3K	﹤0.01%	1342
2018 Q3	$14K	Buy	194 +175	+921%	+$11.5K	﹤0.01%	1106
2018 Q2	$1.56K	Hold	19	–	–	﹤0.01%	1446
2018 Q1	$2K	Buy	19 +4	+27%	+$477	﹤0.01%	1405
2017 Q4	$1K	Buy	+15	New	+$1.84K	﹤0.01%	1607

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Meeder Asset Management's VBIV Position: Q4 2020 in Review

Meeder Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2020, closing a stake of 4 shares.

Meeder Asset Management first reported a position in VBIV in Q4 2017 and held it in 10 quarters. The position peaked at $14K in Q3 2018. 122 funds tracked by Wall St. Rank hold VBIV as of Q4 2020.

Meeder Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2020 after selling out during the quarter.
Meeder Asset Management sold 4 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2020.
Meeder Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 10 quarters.
Meeder Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $14K in Q3 2018.
122 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.